Top Markets
#1 Cross Cross +15.68%
#2 Gama Token Gama Token +8.43%
#3 Glidr Glidr +5.05%
#4 Humanity Humanity +5.03%
#5 TDCCP TDCCP +4.85%
#6 龙虾 (Lobster) 龙虾 (Lobster) +4.82%
#7 Akedo Akedo +4.60%
#8 LEO Token LEO Token +4.58%
#9 Pieverse Pieverse +4.12%
#10 Berachain Berachain +3.39%
Coin of the day
Cross Cross
設定
言語
日本
通貨
USD
テーマ
Guard Therapeutics International AB (publ) Guard Therapeutics International AB (publ)

Guard Therapeutics International AB (publ)

GUARD
株式のランク #36113
Guard Therapeutics International AB (publ) is a Swedish pharmaceutical company... Guard Therapeutics International AB (publ) is a Swedish pharmaceutical company dedicated to the research, development, and commercialization of therapeutic solutions for the diagnosis and management of acute kidney injuries. A key offering is ROSGard, a biological drug candidate designed to prevent kidney impairment through the protection, purification, and restoration of affected cells and tissues. Founded in 2008, the company operated as A1M Pharma AB (publ) until its renaming to Guard Therapeutics International AB (publ) in October 2019. Its headquarters are located in Stockholm, Sweden.
株価
$0.14966934
最終同期: 2026-08-14
時価総額
$3.02M
変化（1日）
3.72%
変化（1年）
-93.70%
国
SE
取引 Guard Therapeutics International AB (publ) (GUARD)

カテゴリー

Healthcare
Guard Therapeutics International AB (publ)（GUARD）の配当利回りの履歴
Guard Therapeutics International AB (publ)（銘柄コード: GUARD）の配当利回り（TTM）は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Guard Therapeutics International AB (publ)（GUARD）の2026から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
年 配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り（TTM）
企業 配当利回り 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
0.48%
BE